文献速递流行病学与生物统计基础与转化研究

用遗传变异区分早年与晚年肥胖对疾病风险的独立效应:孟德尔随机化研究

Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study.
PubMed 文献 · BMJ · 2020-05-06

结果显示,早年体型较大对冠心病和2型糖尿病的总效应主要由成年体型介导;而早年体型较小对乳腺癌有独立保护效应,且青春期启动时间可能独立发挥作用。

要点

  • 早年体型较大对冠心病和2型糖尿病的关联主要由成年体型介导,直接效应证据不足。
  • 早年体型较小对乳腺癌存在独立保护直接效应,与成年体型无关。
  • 初潮年龄独立于早年及成年体型,对乳腺癌有直接因果保护效应。

核心结论

  • 童年体型与成年冠心病和2型糖尿病风险的正关联可归因于个体在成年期持续保持较大体型。
  • 童年体型较小可能独立增加乳腺癌风险,与成年体型无关,青春期启动时间也可能起作用。

研究设计与样本

  • 两样本单变量和多变量孟德尔随机化研究。
  • 暴露为成年期实测体重指数(平均年龄56.5岁)和10岁时自评感知体型。

主要发现

  • 单变量孟德尔随机化显示,遗传预测的早年体型较大与冠心病风险增加相关(每变化一个体型类别OR 1.49,95%CI 1.33–1.68)。
  • 单变量孟德尔随机化显示,遗传预测的早年体型较大与2型糖尿病风险增加相关(OR 2.32,95%CI 1.76–3.05)。
  • 多变量孟德尔随机化未发现早年体型对冠心病(OR 1.02,95%CI 0.86–1.22)和2型糖尿病(OR 1.16,95%CI 0.74–1.82)的直接效应。
  • 多变量孟德尔随机化发现早年体型较大对乳腺癌有保护直接效应(OR 0.59,95%CI 0.50–0.71),成年体型直接效应证据较弱(OR 1.08,95%CI 0.93–1.27)。
  • 将初潮年龄作为额外暴露,多变量孟德尔随机化显示其对乳腺癌有直接因果效应(OR 0.90,95%CI 0.85–0.95)。

关键数值与推荐

  • 冠心病:单变量OR 1.49(95%CI 1.33–1.68),多变量直接效应OR 1.02(95%CI 0.86–1.22)。
  • 2型糖尿病:单变量OR 2.32(95%CI 1.76–3.05),多变量直接效应OR 1.16(95%CI 0.74–1.82)。
  • 乳腺癌:早年体型多变量直接效应OR 0.59(95%CI 0.50–0.71),成年体型直接效应OR 1.08(95%CI 0.93–1.27),初潮年龄多变量直接效应OR 0.90(95%CI 0.85–0.95)。
  • 前列腺癌:早年体型OR 1.06(95%CI 0.81–1.40),成年体型OR 0.87(95%CI 0.70–1.08),均无强因果证据。

临床怎么用

  • 儿童期体型较大者冠心病和2型糖尿病风险升高,主要通过持续至成年的大体型介导,提示成年期体重管理是关键干预窗口。
  • 童年体型较小者乳腺癌风险可能升高,此关联独立于成年体型,需关注该人群的乳腺癌筛查与预防。
  • 初潮年龄较晚对乳腺癌有独立保护效应,青春期发育时机可能是乳腺癌风险分层的有用信息。

局限性

  • 采用两样本孟德尔随机化设计,依赖遗传工具变量有效性假设。
  • 早年体型为10岁时自评感知体型,可能存在回忆偏倚和测量误差。
  • 研究样本主要来自欧洲人群,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether body size in early life has an independent effect on risk of disease in later life or whether its influence is mediated by body size in adulthood. DESIGN: Two sample univariable and multivariable mendelian randomisation. SETTING: The UK Biobank prospective cohort study and four large scale genome-wide association studies (GWAS) consortiums. PARTICIPANTS: 453 169 participants enrolled in UK Biobank and a combined total of more than 700 000 people from different GWAS consortiums. EXPOSURES: Measured body mass index during adulthood (mean age 56.5) and self-reported perceived body size at age 10. MAIN OUTCOME MEASURES: Coronary artery disease, type 2 diabetes, breast cancer, and prostate cancer. RESULTS: Having a larger genetically predicted body size in early life was associated with an increased odds of coronary artery disease (odds ratio 1.49 for each change in body size category unless stated otherwise, 95% confidence interval 1.33 to 1.68) and type 2 diabetes (2.32, 1.76 to 3.05) based on univariable mendelian randomisation analyses. However, little evidence was found of a direct effect (ie, not through adult body size) based on multivariable mendelian randomisation estimates (coronary artery disease: 1.02, 0.86 to 1.22; type 2 diabetes:1.16, 0.74 to 1.82). In the multivariable mendelian randomisation analysis of breast cancer risk, strong evidence was found of a protective direct effect for larger body size in early life (0.59, 0.50 to 0.71), with less evidence of a direct effect of adult body size on this outcome (1.08, 0.93 to 1.27). Including age at menarche as an additional exposure provided weak evidence of a total causal effect (univariable mendelian randomisation odds ratio 0.98, 95% confidence interval 0.91 to 1.06) but strong evidence of a direct causal effect, independent of early life and adult body size (multivariable mendelian randomisation odds ratio 0.90, 0.85 to 0.95). No strong evidence was found of a causal effect of either early or later life measures on prostate cancer (early life body size odds ratio 1.06, 95% confidence interval 0.81 to 1.40; adult body size 0.87, 0.70 to 1.08). CONCLUSIONS: The findings suggest that the positive association between body size in childhood and risk of coronary artery disease and type 2 diabetes in adulthood can be attributed to individuals remaining large into later life. However, having a smaller body size during childhood might increase the risk of breast cancer regardless of body size in adulthood, with timing of puberty also putatively playing a role.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Richardson TG, Sanderson E, Elsworth B, et al. Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study. BMJ. 2020. PMID: 32376654. doi:10.1136/bmj.m1203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。